As new figures show how obesity is rising among children and teenagers, doctors debate if weight loss jabs are the answer ...

New research presented at the European Congress on Obesity (ECO 2025) and published in the journal Diabetes, Obesity and ...

People with mental health problems could be prioritised for weight loss jabs, experts have suggested, after a study showed ...

Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.

Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...

Drugs like Ozempic — which mimic the appetite-suppressing GLP-1 hormone the body naturally produces after eating — have been ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

Metsera is a new GLP-1 player with a Phase 2b injectable and promising oral and amylin drugs in development. Learn why MTSR ...

A novel investigational endoscopic procedure targeting the duodenum appears beneficial in improving glycemic parameters in ...

We expected miracles; what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...

According to a new major clinical trial known as the ESSENCE trial, semaglutide—better known as Ozempic when used for Type 2 ...

Following a similar decision in case the trade group Outsourcing Facilities Association brought against FDA over its decision ...